Home » Stocks » Cleveland BioLabs » Financials » Income Statement

Cleveland BioLabs, Inc. (CBLI)

Stock Price: $2.24 USD 0.00 (0.00%)
Updated Jul 2, 2020 4:00 PM EDT - Market closed

Cleveland BioLabs Income Statement (Annual)

The table below shows the annual income statements for Cleveland BioLabs stock for the past 16 years.

Numbers in millions USD. Fiscal year is January-December.
Year2019201820172016201520142013201220112010200920082007200620052004
Revenue1.111.141.953.522.713.708.493.578.7915.3314.354.712.021.711.140.64
Revenue Growth-2.18%-41.58%-44.62%29.92%-26.84%-56.39%137.71%-59.38%-42.67%6.87%204.87%133.12%18.17%50%78.97%-
Gross Profit1.111.141.953.522.713.708.493.578.7915.3314.354.712.021.711.140.64
Selling, General & Admin1.822.322.503.386.368.4712.0411.1211.119.936.405.8910.532.140.990.26
Research & Development1.663.625.056.507.149.6519.5322.5022.7916.1414.3313.1617.436.992.642.89
Operating Expenses3.475.947.559.8713.5018.1231.5633.6233.9026.0720.7319.0527.989.133.633.16
Operating Income-2.36-4.80-5.60-6.36-10.79-14.42-23.08-30.05-25.11-10.74-6.38-14.35-25.96-7.42-2.49-2.52
Interest Income/Expense-----1.09-------0.010.02-
Other Expense/Income0.29-1.194.11-3.701.85-16.05-5.81-11.81-21.0915.636.44-0.321.04-0.20-0.100.00
Net Income-2.65-3.61-9.71-2.66-12.641.63-17.26-18.23-4.01-26.37-12.83-14.03-27.00-7.22-2.39-2.52
Shares Outstanding11.3011.2911.1910.997.062.702.251.871.631.310.820.670.600.450.310.23
Shares Change0.04%0.91%1.87%55.62%161.22%20.12%20.36%14.82%24.35%59.61%21.59%11.6%35.75%42.49%35.42%-
EPS (Basic)-0.23-0.32-0.87-0.24-1.790.60-7.67-9.75-2.40-20.20-16.40-22.60-46.80-16.80-8.60-11.00
Earnings Per Share (EPS)-0.23-0.32-0.87-0.24-1.790.60-7.67-9.75-2.40-20.20-16.40-22.60-46.80-16.80-8.60-11.00
FCF Per Share-0.23-0.41-0.59-0.44-1.71-5.36-10.33-11.14-10.79-4.86-5.34-18.30-29.10-15.36-6.59-1.02
Gross Margin100%100%100%100%100%100%100%100%100%100%100%100%100%100%100%100%
Operating Margin-212.0%-421.7%-287.5%-180.6%-398.5%-389.6%-271.9%-841.5%-285.6%-70.0%-44.5%-304.9%-1,285.9%-434.3%-218.5%-395.9%
Profit Margin-237.7%-317.3%-498.2%-75.6%-466.6%44%-203.4%-510.7%-45.7%-172%-93.7%-323.2%-1400.1%-435.4%-235.2%-396.5%
FCF Margin-234.8%-404.6%-339.1%-137.9%-445.8%-391.0%-273.8%-583.3%-199.8%-41.5%-30.5%-262.4%-871.6%-400.5%-180.8%-37.1%
EBITDA-2.63-3.59-9.69-2.60-12.363.56-16.79-17.75-3.49-25.96-12.46-13.70-26.81-7.12-2.32-2.52
EBITDA Margin-236.5%-315.7%-497.1%-73.8%-456.5%96.2%-197.8%-497.2%-39.7%-169.3%-86.9%-291.2%-1328%-416.6%-204%-395.5%
EBIT-2.65-3.61-9.71-2.66-12.642.72-17.26-18.23-4.01-26.37-12.83-14.03-27.00-7.21-2.37-2.52
EBIT Margin-237.7%-317.3%-498.2%-75.6%-466.6%73.4%-203.4%-510.7%-45.7%-172.0%-89.4%-298.1%-1,337.4%-422.2%-208.0%-395.9%